China Universal Asset Management Company’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.4M | Buy |
149,007
+975
| +0.7% | +$68.1K | 0.98% | 20 |
|
|
2025
Q1 | $10.9M | Sell |
148,032
-1,764
| -1% | -$130K | 1.01% | 17 |
|
|
2024
Q4 | $9.81M | Buy |
149,796
+30,414
| +25% | +$1.99M | 0.92% | 19 |
|
|
2024
Q3 | $9.3M | Buy |
119,382
+59,999
| +101% | +$4.67M | 1.03% | 19 |
|
|
2024
Q2 | $4.63M | Sell |
59,383
-55,141
| -48% | -$4.3M | 0.65% | 40 |
|
|
2024
Q1 | $7.76M | Buy |
114,524
+49,049
| +75% | +$3.32M | 0.99% | 27 |
|
|
2023
Q4 | $4.41M | Buy |
65,475
+48,349
| +282% | +$3.26M | 0.86% | 34 |
|
|
2023
Q3 | $1.16M | Buy |
17,126
+8,812
| +106% | +$597K | 0.34% | 75 |
|
|
2023
Q2 | $595K | Sell |
8,314
-37
| -0.4% | -$2.65K | 0.18% | 102 |
|
|
2023
Q1 | $580K | Buy |
8,351
+2,144
| +35% | +$149K | 0.2% | 90 |
|
|
2022
Q4 | $421K | Buy |
6,207
+497
| +9% | +$33.7K | 0.17% | 89 |
|
|
2022
Q3 | $313K | Buy |
+5,710
| New | +$313K | 0.13% | 86 |
|